| |
| |
|
| Insider
Information: |
Brownlie Keith L |
| Relationship: |
Director |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
445,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$384,340 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
445,000 |
|
|
| Total
Value |
$384,340 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Soligenix Inc Common |
SNGX |
Director |
2015-04-09 |
50,000 |
2013-06-25 |
0 |
Premium* |
|
|
Epicept Corp |
IMNP |
Director |
2013-08-12 |
360,000 |
2013-08-12 |
0 |
Premium* |
|
|
Vyant Bio Ord Shs |
VYNT |
Director |
2014-05-22 |
5,000 |
2014-05-22 |
0 |
Premium* |
|
|
Celldex Therapeutics Inc |
CLDX |
Director |
2017-06-15 |
10,000 |
2017-06-15 |
0 |
Premium* |
|
|
Phio Pharmaceuticals Corp |
PHIO |
Director |
2019-02-13 |
20,000 |
2018-08-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PHIO |
Phio Pharmaceuticals Corp |
Director |
– • – |
2019-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
20,000 |
0 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
Director |
– • – |
2018-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
Director |
– • – |
2017-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| SNGX |
Soligenix Inc Common |
Director |
– • – |
2015-04-09 |
4 |
OE |
$0.61 |
$8,714 |
D/D |
14,286 |
50,000 |
0 |
- |
|
| VYNT |
Vyant Bio Ord Shs |
Director |
– • – |
2014-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| SNGX |
Soligenix Inc Common |
Director |
– • – |
2014-05-14 |
4 |
OE |
$0.30 |
$5,000 |
D/D |
16,667 |
35,714 |
0 |
- |
|
| IMNP |
Epicept Corp |
Director |
– • – |
2013-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
360,000 |
0 |
- |
|
| SNGX |
Soligenix Inc Common |
Director |
– • – |
2013-06-25 |
4 |
B |
$1.05 |
$19,999 |
D/D |
19,047 |
19,047 |
2.39 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
